TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer

OBJECTIVE: To evaluate the effectiveness and safety of TAS-102 monotherapy and combination therapy with bevacizumab in the treatment of metastatic colorectal cancer. METHODS: The PubMed, Web of Science, MEDLINE, and Cochrane Library databases were searched for the literature on TAS-102 treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cheng-Jiang, Hu, Ting, Shao, Ping, Chu, Wu-Yang, Cao, Yu, Zhang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712127/
https://www.ncbi.nlm.nih.gov/pubmed/34966426
http://dx.doi.org/10.1155/2021/4014601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712127/
https://www.ncbi.nlm.nih.gov/pubmed/34966426
http://dx.doi.org/10.1155/2021/4014601

Ejemplares similares